About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2201-2220 of 4,039 trials

UnknownEfficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian CancerThis study was designed to assess the safety and efficacy of neoadjuvant therapy with mitomycin C plus cisplatin (MP) in BRCA1-mutated ovarian cancer versus standard regimen…NCT04747717·Saint Petersburg, Pesochny-2, St.-Petersburg RecruitingA Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant TumorsThe study is being conducted to explore the reasonable dosage and evaluate the efficacy, safety and tolerability of HLX43 (Anti-PD-L1 ADC) in patients with recurrent/metastatic…NCT06769152·Ji'nan, Shandong Active not recruitingMirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian CancerThis is a multi-center, randomized, two-arm, open-label, comparative phase II trial of Mirvetuximab soravtansine (IMGN853), in folate receptor alpha (FRα) high recurrent ovarian…NCT04274426·Berlin and 18 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

CompletedImpact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer SurgeryThis is a single-center, randomized, phase II, non-comparative, single-blind clinical study that will determine whether morphine reduction through intraoperative monitoring by ANI…NCT04906187·Bordeaux

CompletedAn Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationDoctors will take some tissue from the tissue removed during surgery in order to study how the blood vessels of the tumor respond to radiation therapy.NCT00132704·New York, New York

CompletedPrehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PatientsThis clinical trial evaluates whether a prehabilitation program started at the time of neoadjuvant chemotherapy will affect surgical recovery in patients with stage IIIC-IV…NCT05047926·Rochester, Minnesota

UnknownComparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage Ovarian CancerOvarian cancer is a lethal malignancy and reported as a fifth leading cause of death in all age in the developed country.NCT03448354·Suwon, Gyeonggi-do

CompletedA Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid TumorsThis study is a first-in-human, Phase 1, open label, multicenter, dose escalation study with expansion at the RP2D, to evaluate the safety, tolerability, and preliminary efficacy…NCT05074472·Phoenix, Arizona and 8 others

CompletedA Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesThe purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02390 in participants with select advanced malignancies.NCT03652077·Los Angeles, California and 3 others

CompletedRisk of Ovarian Cancer in Patients With a Pelvic MassThe purpose of this clinical trial is to evaluate the ability of multiple serum biomarkers to estimate the risk of ovarian cancer in women presenting with pelvic mass (defined as…NCT00315692·Malvern, Pennsylvania and 1 other

TerminatedIGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing SurgeryThis phase II trial studies how well pUMVC3-IGFBP2 plasmid deoxyribonucleic acid (DNA) vaccine (IGFBP-2 vaccine) and combination chemotherapy work in treating patients with stage…NCT03029611·Seattle, Washington

CompletedPhase II ABT-888 With CyclophosphamideBackground: \- The experimental cancer treatment drug ABT-888 (Veliparib) works by preventing deoxyribonucleic acid (DNA) repair in tumor cells.NCT01306032·Davis, California and 9 others

TerminatedPEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerRATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer cells.NCT00085384·Houston, Texas

CompletedA Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerRATIONALE: Drugs used in chemotherapy, such as carboplatin and pegylated liposomal doxorubicin hydrochloride (PLD) work in different ways to stop the growth of tumor cells, either…NCT01281514·Philadelphia, Pennsylvania

RecruitingA Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Researchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer cells grow and spread quickly.NCT06843447·New Haven, Connecticut and 32 others

UnknownTreat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pillscomparison between cocs and progesterone only containing pills in treatment of fuctional ovarian cystNCT05244811

RecruitingPhase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyTo find out if combining pembrolizumab, bevacizumab (or an equivalent biosimilar drug), and low-dose cyclophosphamide can help control high-grade ovarian cancer that has MRD after…NCT06083844·New York, New York and 1 other

UnknownEfficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian CancerTo evaluate the efficacy and safety of niraparib combined with oral etoposide in platinum resistant or platinum refractory recurrent ovarian cancer.NCT04217798·Beijing and 1 other

CompletedStudy of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerTo evaluate whether AMG 386 in combination with paclitaxel and carboplatin is safe and well tolerated in the first-line treatment of high-risk stage I and stages II-IV epithelial…NCT01253681·Footscray, Victoria and 7 others

CompletedAlisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerThis is an open-label, multicenter study with a nonrandomized Phase 1 portion and an open-label, randomized, Phase 2 portion evaluating MLN8237 in combination with weekly…NCT01091428·The Bronx, New York and 3 others

PreviousPage 111 of 202Next